查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589504

數位藥局市場：按藥物類型、平台分類 - 2025-2030 年全球預測

Digital Pharmacy Market by Drug Type (Over-The-Counter Drugs, Prescription Drugs), Platform (Apps, Websites) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年數位藥局市場規模為1,389.1億美元，預計2024年將達1,649.1億美元，複合年成長率為19.20%，2030年將達4,750.8億美元。

數位藥局市場包括透過數位方式促進藥品和服務分銷的線上平台。該市場包括電子處方、線上藥物管理、數位諮詢以及透過網路和行動應用程式提供的處方藥交付服務。對數位藥局不斷成長的需求是由患者對便利性的偏好、改善獲得廣泛的醫療保健服務以及改善藥物依從性管理所推動的，特別是隨著慢性病的增加和人口老齡化的發生。應用範圍從遠端醫療諮詢和與醫療保健系統的無縫整合到簡化處方箋補充和用藥歷史管理。最終使用領域包括尋求提供更全面、更具成本效益的解決方案的個人消費者、醫療保健提供者和保險公司。

主要市場統計
基準年[2023] 1389.1億美元
預測年份 [2024] 1649.1億美元
預測年份 [2030] 4750.8億美元
複合年成長率（%） 19.20%

市場成長受到醫療保健 IT 技術進步、智慧型手機和網路普及率的提高以及促進電子醫療計劃的支持性政府法規等因素的影響。 COVID-19 大流行透過加速數位醫療解決方案並解決傳統醫療保健服務系統的差距，為新興市場和服務不足的社區提供了持續成長的機會。然而，挑戰也存在，包括資料隱私和安全問題、監管合規的複雜性以及來自老牌實體藥局的競爭。此外，付款人和醫療保健提供者可能會猶豫是否要全面轉型，因為這可能會破壞現有的照護模式。

低收入地區的技術基礎設施和數位素養差異等問題也阻礙了廣泛採用。因此，數位藥局市場的創新可能集中在改善網路安全措施、開拓方便用戶使用的平台以及增強人工智慧主導的個人化服務，例如自動重新處方提醒和藥物交互作用檢查。此外，與高科技公司的跨境合作和夥伴關係可以釋放進一步的進步。市場的本質是動態的，新參與企業突破傳統界限，提供客製化的、以患者為中心的服務，對現有企業提出挑戰，同時承諾擴充性和改善的醫療保健結果，因此，可能會發生重大破壞。

市場動態：揭示快速發展的數位藥局市場的關鍵市場洞察

供需的動態交互作用正在改變數位藥局市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 消費者越來越偏好在線上購買藥品
    • 政府不斷加強數位化舉措
    • 需要監控不斷擴大的數位療法和患者特定資料的可用性
  • 市場限制因素
    • 患者依賴線下藥師進行臨床支持
  • 市場機會
    • 擴大遠端保健和遠端醫療的採用
    • 智慧鏡科技與居家醫療診斷工具的整合與融合
  • 市場挑戰
    • 安全問題和非法網路藥局的存在

波特五力：駕馭數位藥局市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解數位藥局市場的外部影響

外部宏觀環境因素在塑造數位藥局市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解數位藥局市場的競爭狀況

數位藥局市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 數位藥局市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估數位藥局市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了數位藥房市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，數位藥房市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 消費者在網路上購買藥品的偏好增加
      • 政府加大數位化力度
      • 需要監控不斷成長的數位療法和患者特定資料的可用性
    • 抑制因素
      • 患者依賴離線藥師提供臨床支持
    • 機會
      • 擴大遠端醫療引進和遠距醫療
      • 智慧鏡子技術與家庭健康篩檢工具的整合與嵌入
    • 任務
      • 對安全和非法網上藥局存在的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按藥物類型分類的數位藥局市場

  • 非處方藥
  • 處方藥

第7章數位藥局市場：依平台

  • 應用程式
  • 網站

第8章美洲數位藥局市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區數位藥局市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的數位藥局市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AdhereHealth, LLC
  • Amazon.com, Inc.
  • Apollo Pharmacies Limited
  • Costco Wholesale Corporation
  • Digital Pharmacist, Inc.
  • Giant Eagle Inc.
  • GoodRx, Inc.
  • Healthwarehouse,.Inc
  • Hims & Hers Health, Inc.
  • Optum, Inc.
  • Pharmex Direct Inc.
  • Rite Aid Corporation
  • The Kroger Co.
  • Walgreen Co.
  • Walmart Inc.
Product Code: MRR-0D217D5AF4FB

The Digital Pharmacy Market was valued at USD 138.91 billion in 2023, expected to reach USD 164.91 billion in 2024, and is projected to grow at a CAGR of 19.20%, to USD 475.08 billion by 2030.

The digital pharmacy market encompasses online platforms that facilitate the distribution of pharmaceutical products and services through digital means. This market includes e-prescribing, online medication management, digital consultations, and delivery services of prescribed medicines via web and mobile applications. The growing necessity for digital pharmacies stems from the increasing patient preference for convenience, enhanced accessibility to a broader range of healthcare services, and improved management of medication adherence, especially amid the rise of chronic diseases and the aging population. Its application ranges from telehealth consultations and seamless integration with healthcare systems to streamlining prescription refills and medication history management. End-use sectors span individual consumers, healthcare providers, and insurance companies looking to offer more comprehensive and cost-effective solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 138.91 billion
Estimated Year [2024] USD 164.91 billion
Forecast Year [2030] USD 475.08 billion
CAGR (%) 19.20%

Market growth is influenced by factors such as technological advancements in health IT, increasing smartphone and internet penetration, and supportive government regulations promoting e-health initiatives. The COVID-19 pandemic accelerated the adoption of digital health solutions, presenting persistent growth opportunities in emerging markets and underserved communities by addressing gaps in traditional healthcare delivery systems. However, challenges exist, including concerns over data privacy and security, regulatory compliance complexities, and competition from well-established brick-and-mortar pharmacies. Payers and providers may also hesitate to transition fully due to potential disruptions in existing care models.

Limitations revolve around technology infrastructure in low-income regions and the digital literacy divide that may hinder widespread adoption. Consequently, innovation within the digital pharmacy market can focus on improving cybersecurity measures, developing user-friendly platforms, and enhancing artificial intelligence driven personalization in services, such as automatic refill reminders or medication interaction checks. Moreover, cross-border collaborations and partnerships with tech firms could unlock further advancements. The market's nature is dynamic, with potential for substantial disruption as new entrants arrive, pushing traditional borders and offering tailored, patient-centric services that challenge incumbents while promising scalability and improved healthcare outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Pharmacy Market

The Digital Pharmacy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing consumer preference towards buying medicines online
    • Rising government initiatives towards digitalization
    • Need to monitor growing availability of digital therapeutics and patient-specific data
  • Market Restraints
    • Patients reliance on offline pharmacists for clinical support
  • Market Opportunities
    • Growing adoption of telehealth and telemedicine
    • Integration and incorporation of smart mirrors technology and home health diagnostic tools
  • Market Challenges
    • Concerns related to security and presence of illegal online pharmacies

Porter's Five Forces: A Strategic Tool for Navigating the Digital Pharmacy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Pharmacy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Pharmacy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Pharmacy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Pharmacy Market

A detailed market share analysis in the Digital Pharmacy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Pharmacy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Pharmacy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Pharmacy Market

A strategic analysis of the Digital Pharmacy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Pharmacy Market, highlighting leading vendors and their innovative profiles. These include AdhereHealth, LLC, Amazon.com, Inc., Apollo Pharmacies Limited, Costco Wholesale Corporation, Digital Pharmacist, Inc., Giant Eagle Inc., GoodRx, Inc., Healthwarehouse,.Inc, Hims & Hers Health, Inc., Optum, Inc., Pharmex Direct Inc., Rite Aid Corporation, The Kroger Co., Walgreen Co., and Walmart Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Pharmacy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Over-The-Counter Drugs and Prescription Drugs.
  • Based on Platform, market is studied across Apps and Websites.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing consumer preference towards buying medicines online
      • 5.1.1.2. Rising government initiatives towards digitalization
      • 5.1.1.3. Need to monitor growing availability of digital therapeutics and patient-specific data
    • 5.1.2. Restraints
      • 5.1.2.1. Patients reliance on offline pharmacists for clinical support
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adoption of telehealth and telemedicine
      • 5.1.3.2. Integration and incorporation of smart mirrors technology and home health diagnostic tools
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to security and presence of illegal online pharmacies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Pharmacy Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Over-The-Counter Drugs
  • 6.3. Prescription Drugs

7. Digital Pharmacy Market, by Platform

  • 7.1. Introduction
  • 7.2. Apps
  • 7.3. Websites

8. Americas Digital Pharmacy Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Digital Pharmacy Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Digital Pharmacy Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AdhereHealth, LLC
  • 2. Amazon.com, Inc.
  • 3. Apollo Pharmacies Limited
  • 4. Costco Wholesale Corporation
  • 5. Digital Pharmacist, Inc.
  • 6. Giant Eagle Inc.
  • 7. GoodRx, Inc.
  • 8. Healthwarehouse,.Inc
  • 9. Hims & Hers Health, Inc.
  • 10. Optum, Inc.
  • 11. Pharmex Direct Inc.
  • 12. Rite Aid Corporation
  • 13. The Kroger Co.
  • 14. Walgreen Co.
  • 15. Walmart Inc.

LIST OF FIGURES

  • FIGURE 1. DIGITAL PHARMACY MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL PHARMACY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL PHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DIGITAL PHARMACY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DIGITAL PHARMACY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL PHARMACY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL PHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL PHARMACY MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY APPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY WEBSITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 99. DIGITAL PHARMACY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. DIGITAL PHARMACY MARKET, FPNV POSITIONING MATRIX, 2023